Overview: Genetic Profile TestIntroduction: The Genetic Profile Test tests for a panel of genetic mutations to assess risk for inherited disorders, helping guide family planning or early interventions. Affecting 1 in 100 people with family history, these disorders pose diagnostic challenges due to genetic diversity. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses PCR/sequencing for high accuracy, supporting molecular pathology screening. This test is vital for risk assessment, counseling, and improving outcomes in genetics.
Other Names: Genetic Risk Panel Test, Hereditary Disorder Assay.
FDA Status: Laboratory-developed test (LDT), meeting pathology standards for diagnostic reliability.
Historical Milestone: Genetic screening began in the 1990s with research by Collins, who advanced gene mapping. PCR/sequencing advancements in the 2000s by Illumina improved detection, surpassing earlier single-gene tests.
Purpose: Detects genetic mutations to assess inherited disorder risk, guides family planning or interventions, and evaluates patients with family history, aiming to prevent disease.
Test Parameters: Genetic mutation panel
Pretest Condition: No special preparation required. Collect whole blood, buccal swab, or saliva. Report family medical history.
Specimen: Whole Blood (EDTA, 3-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL); 4 mL whole blood in EDTA tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document family history of genetic disorders. Include current medications or pregnancy status.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., carrier status), and sample collection risks.
Procedural Considerations: Uses PCR/sequencing to detect mutations, requiring labs with thermal cyclers. Results available in 5-7 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Positive mutations indicate risk, guiding counseling. Early intervention might prevent disease, while negative results may require follow-up. Results need interpretation.
Specialist Consultation: Consult a genetic counselor for interpretation.
Additional Supporting Tests: Specific gene tests, biochemical assays, or family studies to confirm diagnosis.
Test Limitations: Panel-specific; correlation with family history needed. False negatives possible with untested variants.
References: ACMG Guidelines, 2023; Nature Genetics, Collins FS, 2022.
